BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37635268)

  • 1. Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine.
    Valvassori SS; da Rosa RT; Dal-Pont GC; Varela RB; Mastella GA; Daminelli T; Fries GR; Quevedo J; Zugno AI
    Int J Dev Neurosci; 2023 Dec; 83(8):691-702. PubMed ID: 37635268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus.
    Pillai A; Terry AV; Mahadik SP
    Schizophr Res; 2006 Feb; 82(1):95-106. PubMed ID: 16442781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
    Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
    Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment.
    Becker A; Grecksch G; Schwegler H; Roskoden T
    Med Chem; 2008 May; 4(3):256-63. PubMed ID: 18473918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine Produces Antidepressant Effects by Inhibiting Histone Deacetylases and Upregulating Hippocampal Brain-Derived Neurotrophic Factor Levels in a Diisopropyl Fluorophosphate-Based Rat Model of Gulf War Illness.
    Ribeiro-Davis A; Al Saeedy DY; Jahr FM; Hawkins E; McClay JL; Deshpande LS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):647-654. PubMed ID: 37863487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats.
    Morcuende S; Muñoz-Hernández R; Benítez-Temiño B; Pastor AM; de la Cruz RR
    Neuroscience; 2013 Oct; 250():31-48. PubMed ID: 23827308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.
    Angelucci F; Mathé AA; Aloe L
    Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lithium and valproate on behavioral parameters and neurotrophic factor levels in an animal model of mania induced by paradoxical sleep deprivation.
    Dal-Pont GC; Jório MTS; Resende WR; Gava FF; Aguiar-Geraldo JM; Possamai-Della T; Peper-Nascimento J; Quevedo J; Valvassori SS
    J Psychiatr Res; 2019 Dec; 119():76-83. PubMed ID: 31574363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia.
    Zugno AI; Pacheco FD; Budni J; de Oliveira MB; Canever L; Heylmann AS; Wessler PG; da Rosa Silveira F; Mastella GA; Gonçalves CL; Freitas KV; de Castro AA; Streck EL; Quevedo J
    Metab Brain Dis; 2015 Aug; 30(4):1043-53. PubMed ID: 25920483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase.
    Canever L; Freire TG; Mastella GA; Damázio L; Gomes S; Fachim I; Michels C; Carvalho G; Godói AK; Peterle BR; Gava FF; Valvassori SS; Budni J; Quevedo J; Zugno AI
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():52-64. PubMed ID: 29782958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
    Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
    Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes.
    Viana GSB; Vale EMD; Araujo ARA; Coelho NC; Andrade SM; Costa ROD; Aquino PEA; Sousa CNS; Medeiros IS; Vasconcelos SMM; Neves KRT
    Braz J Med Biol Res; 2020; 54(2):e10107. PubMed ID: 33331415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol and aripiprazole impact on the BDNF and glucocorticoid receptor levels in the rat hippocampus and prefrontal cortex: effect of the chronic mild stress.
    Osacka J; Koprdova R; Tillinger A; Pirnik Z; Kiss A
    Endocr Regul; 2021 Sep; 55(3):153-162. PubMed ID: 34523299
    [No Abstract]   [Full Text] [Related]  

  • 19. Haloperidol elicits oxidative damage in the brain of rats submitted to the ketamine-induced model of schizophrenia.
    Valvassori SS; Cararo JH; Menegas S; Possamai-Della T; Aguiar-Geraldo JM; Araujo SL; Mastella GA; Quevedo J; Zugno AI
    Brain Res Bull; 2021 May; 170():246-253. PubMed ID: 33545309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.
    Dong E; Dzitoyeva SG; Matrisciano F; Tueting P; Grayson DR; Guidotti A
    Biol Psychiatry; 2015 Mar; 77(6):589-96. PubMed ID: 25444166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.